Company
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Adebrelimab | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Shanghai Hengrui Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.